MedPath

ZANTAC

(ranitidine) Injection Rx only

Approved
Approval ID

95dc4515-7690-4881-ae14-9f8655a68dfe

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 21, 2020

Manufacturers
FDA

Teligent, Inc.

DUNS: 011036910

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ranitidine hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code52565-096
Application NumberNDA019090
Product Classification
M
Marketing Category
C73594
G
Generic Name
ranitidine hydrochloride
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateMay 21, 2020
FDA Product Classification

INGREDIENTS (4)

RANITIDINE HYDROCHLORIDEActive
Quantity: 25 mg in 1 mL
Code: BK76465IHM
Classification: ACTIM
PHENOLInactive
Code: 339NCG44TV
Classification: IACT
POTASSIUM PHOSPHATE, MONOBASICInactive
Code: 4J9FJ0HL51
Classification: IACT
SODIUM PHOSPHATE, DIBASICInactive
Code: GR686LBA74
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ZANTAC - FDA Drug Approval Details